100 related articles for article (PubMed ID: 23312240)
1. Narrow-band imaging in laparoscopic management of recurrent platinum sensitive ovarian cancer.
Gagliardi ML; Polito S; Fagotti A; Fanfani F; Scambia G
J Minim Invasive Gynecol; 2013; 20(1):10-2. PubMed ID: 23312240
[No Abstract] [Full Text] [Related]
2. [Related-factor analysis on efficacy of re-platinum chemotherapy in platinum-sensitive recurrent ovarian carcinoma].
Cheng XD; Lü WG; Xie X; Huang XF; Ye DF; He HC; Ding ZM
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):670-2. PubMed ID: 14728853
[TBL] [Abstract][Full Text] [Related]
3. Unusual presentation of stage I ovarian cancer associated with 20 litres of ascites.
Cartwright B; Papachalarabous E; Tailor A
J Obstet Gynaecol; 2008 Jan; 28(1):123-5. PubMed ID: 18259927
[No Abstract] [Full Text] [Related]
4. A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET/CT and staging laparoscopy.
Fagotti A; Fanfani F; Rossitto C; Lorusso D; De Gaetano AM; Giordano A; Vizzielli G; Scambia G
Oncology; 2008; 75(3-4):152-8. PubMed ID: 18827492
[TBL] [Abstract][Full Text] [Related]
5. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Pan HS; Lee SL; Huang LW; Chen YK
Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
[TBL] [Abstract][Full Text] [Related]
6. Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer?
Abou-Jawde RM; Oberoi SS
J Clin Oncol; 2008 May; 26(15):2602-3; author reply 2603. PubMed ID: 18487582
[No Abstract] [Full Text] [Related]
7. Concomitant Laparoscopic and Thoracoscopic Resection of Recurrent High-Grade Ovarian Cancer.
Tozzi R; Casarin J; Belcher E; Garruto Campanile R; Ismail L; Soleymani Majd H; Morotti M; Desgro M
J Minim Invasive Gynecol; 2018; 25(7):1148. PubMed ID: 29501813
[TBL] [Abstract][Full Text] [Related]
8. Microlaparoscopy: a new approach to the reassessment of ovarian cancer patients.
Franchi M; Ghezzi F; Beretta P; Donadello N; Miglierina M; Zanaboni F
Acta Obstet Gynecol Scand; 2000 May; 79(5):427-30. PubMed ID: 10830772
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic adnexectomy with peritonectomy for an ovarian tumor adhered to the pelvic sidewall.
Kobayashi E; Kanao H; Andou M
Gynecol Obstet Invest; 2013; 75(4):250-4. PubMed ID: 23548802
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of CI-958 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.
Hoffman MA; Blessing JA; Nuñez ER
Gynecol Oncol; 2001 Jun; 81(3):433-5. PubMed ID: 11371134
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of CI-958 in recurrent platinum-refractory ovarian carcinoma. A Gynecologic Oncology Group Study.
Hoffman MA; Blessing JA; Morgan M
Gynecol Oncol; 2000 Dec; 79(3):463-5. PubMed ID: 11104620
[TBL] [Abstract][Full Text] [Related]
12. Do Not Give Up.
Roux RL; Hall MR; Rustin GJS; Zweifel M
Int J Gynecol Cancer; 2017 Jul; 27(6):1060-1062. PubMed ID: 26575275
[No Abstract] [Full Text] [Related]
13. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
du Bois A; Lück HJ; Meerpohl HG
Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis.
Mansueto M; Grimaldi A; Mangili G; Picchio M; Giovacchini G; Viganò R; Messa C; Fazio F
Eur J Cancer Care (Engl); 2009 Nov; 18(6):612-9. PubMed ID: 19549284
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer.
Hauth EA; Antoch G; Stattaus J; Kuehl H; Veit P; Bockisch A; Kimmig R; Forsting M
Eur J Radiol; 2005 Nov; 56(2):263-8. PubMed ID: 16233894
[TBL] [Abstract][Full Text] [Related]
16. [Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives].
Bliumenberg AG; Gorbacheva LB; Gorbunova VA; Kozachenko VP; Lankin VZ
Biull Eksp Biol Med; 1996 Dec; 122(12):651-4. PubMed ID: 9280465
[No Abstract] [Full Text] [Related]
17. Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
Pignata S; Ferrandina G; Scarfone G; Scollo P; Odicino F; Cormio G; Katsaros D; Frigerio L; Mereu L; Ghezzi F; Manzione L; Lauria R; Breda E; Alletti DG; Ballardini M; Vernaglia A; Sorio R; Tumolo S; Musso P; Magni G; Pisano C; Morabito A
Crit Rev Oncol Hematol; 2009 Sep; 71(3):233-41. PubMed ID: 19179095
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: a Gynecologic Oncology Group study.
Plaxe SC; Blessing JA; Bookman MA; Creasman WT
Gynecol Oncol; 2002 Jan; 84(1):32-5. PubMed ID: 11748972
[TBL] [Abstract][Full Text] [Related]
19. Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer.
Ushijima K; Ota S; Komai K; Matsuo G; Motoshima S; Honda S; Tomonari R; Sugiyama T; Kamura T
Int Surg; 2002; 87(3):185-90. PubMed ID: 12403096
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of PET-CT imaging versus AGO-scoring in patients planned for cytoreductive surgery in recurrent ovarian cancer.
Lenhard SM; Burges A; Johnson TR; Kirschenhofer A; Bruns C; Linke R; Friese K
Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):263-8. PubMed ID: 18614272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
